Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN119661449B reveals efficient synthesis. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates manufacturing globally.
Advanced refining method for Fasudil Hydrochloride ensures high purity and cost reduction. Ideal for pharmaceutical intermediates manufacturing and supply chain reliability.
Novel synthesis method for MEK inhibitor intermediates ensures safety and scalability for global supply chains.
Patent CN1046523C details a high-yield phosgene-mediated coupling process for quinolone lactam antibacterial agents, offering significant cost reduction in API manufacturing.
Patent CN104447234A details a novel synthetic route for anti-pancreatic cancer intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103626630B reveals a cost-effective Rivaroxaban intermediate synthesis. Enhances supply chain reliability and reduces manufacturing能耗 for pharmaceutical partners.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.
Patent CN103626630B reveals a novel catalytic hydrogenation route for Rivaroxaban intermediates, offering significant cost reduction and scalable high-purity manufacturing for global supply chains.
Novel patent CN110028461A enables high-purity candesartan cilexetil production with improved supply chain stability and significant cost efficiency for global buyers.
Patent CN104844476B reveals advanced biphenyl synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthetic route for fexofenadine avoiding isomer separation. High yield, simple process, cost-effective manufacturing for pharmaceutical intermediates.
Advanced semi-synthetic route for Paclitaxel and Docetaxel offering high yield and purity. Optimized for cost reduction in API manufacturing and supply chain stability.
Patent CN103351361B details a novel Pd-catalyzed oxidation route for Levocetirizine Dihydrochloride ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel industrial method for Dasatinib synthesis avoiding palladium catalysts, offering cost reduction and scalable production for pharmaceutical manufacturers.
Novel one-pot synthesis using PEG-400 solvent offers high yield and green chemistry advantages for scalable pharmaceutical intermediate manufacturing.
Patent CN115385971A details a novel NMN preparation method using phosphorus pentoxide to eliminate arsenic residues and reduce wastewater phosphorus for cost-effective manufacturing.
Patent CN114478580A reveals a recyclable ionic liquid method for synthesizing pyrano thiazolo pyrimidine derivatives, offering high purity and reduced waste for API manufacturing.
Patent CN102746360B details novel camptothecin-steroid conjugates with enhanced antitumor activity. Discover cost-effective EDCI-DMAP synthesis routes for high-purity API intermediates.
Advanced patent CN104016954A method for nebivolol intermediate. High yield, >99% purity, scalable process for reliable pharmaceutical intermediate supplier.
Patent CN112142750B reveals a green one-pot synthesis for triazolo pyrimidine derivatives using acidic ionic liquids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.